ProfileGDS4718 / 244875_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 74% 78% 72% 80% 70% 68% 71% 79% 72% 76% 70% 71% 70% 67% 67% 70% 69% 71% 70% 83% 82% 71% 71% 71% 72% 67% 71% 76% 73% 71% 68% 69% 77% 72% 67% 68% 72% 76% 75% 69% 70% 70% 67% 68% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]7.1998774
GSM549102patient 115, normal, homogenized [OPG study]7.6113478
GSM549104patient 119, normal, homogenized [OPG study]7.0879772
GSM549108patient 138, normal, homogenized [OPG study]7.7202980
GSM549119patient 077, normal, homogenized [OPG study]6.8779470
GSM549133patient 032, cancer, homogenized [OPG study]6.7042968
GSM549139patient 042, cancer, homogenized [OPG study]6.942971
GSM549099patient 107, normal, homogenized [OPG study]7.7057479
GSM549109patient 139, normal, homogenized [OPG study]7.0459172
GSM549110patient 046, normal, homogenized [OPG study]7.417976
GSM549114patient 063, normal, homogenized [OPG study]6.8803370
GSM549122patient 082, normal, homogenized [OPG study]6.9757571
GSM549134patient 033, cancer, homogenized [OPG study]6.8298170
GSM549136patient 036, cancer, homogenized [OPG study]6.6403467
GSM549140patient 044, cancer, homogenized [OPG study]6.6652967
GSM549111patient 047, normal, homogenized [OPG study]6.90270
GSM549113patient 057, normal, homogenized [OPG study]6.7718769
GSM549132patient 031, cancer, homogenized [OPG study]6.9927371
GSM549137patient 038, cancer, homogenized [OPG study]6.8664770
GSM549142patient 047, cancer, homogenized [OPG study]7.9091283
GSM549100patient 110, normal, homogenized [OPG study]8.0098982
GSM549107patient 135, normal, homogenized [OPG study]6.9736171
GSM549115patient 068, normal, homogenized [OPG study]6.9915371
GSM549116patient 072, normal, homogenized [OPG study]6.9694471
GSM549120patient 078, normal, homogenized [OPG study]7.0197172
GSM549131patient 030, cancer, homogenized [OPG study]6.6196167
GSM549118patient 074, normal, homogenized [OPG study]7.0017971
GSM549129patient 027, cancer, homogenized [OPG study]7.4578576
GSM549123patient 088, normal, homogenized [OPG study]7.1445273
GSM549124patient 006, cancer, homogenized [OPG study]6.9176971
GSM549126patient 015, cancer, homogenized [OPG study]6.7411768
GSM549128patient 025, cancer, homogenized [OPG study]6.8566269
GSM549103patient 117, normal, homogenized [OPG study]7.3889377
GSM549117patient 073, normal, homogenized [OPG study]6.983872
GSM549138patient 041, cancer, homogenized [OPG study]6.6700567
GSM549141patient 045, cancer, homogenized [OPG study]6.7596368
GSM549130patient 028, cancer, homogenized [OPG study]7.0381372
GSM549101patient 111, normal, homogenized [OPG study]7.4482776
GSM549105patient 128, normal, homogenized [OPG study]7.2809275
GSM549106patient 134, normal, homogenized [OPG study]6.8909469
GSM549112patient 048, normal, homogenized [OPG study]6.8904370
GSM549125patient 011, cancer, homogenized [OPG study]6.8600170
GSM549127patient 024, cancer, homogenized [OPG study]6.7157967
GSM549135patient 035, cancer, homogenized [OPG study]6.777868